Abstract
Evaluation of: Thiele H, Zeymer U, Neumann FJ et al; IABP-SHOCK II Trial Investigators. Intra-aortic balloon support for myocardial infarction with cardiogenic shock. N. Engl. J. Med. 367(14), 1287–1296 (2012).Cardiogenic shock (CS) in acute myocardial infarction (AMI) is associated with high mortality. Ventricular support devices such as intra-aortic balloon pumps have been used in the acute management of this condition. However, a recent randomized controlled trial conducted by Thiele et al. showed that the use of an intra-aortic balloon pump in CS in AMI does not improve 30-day outcomes in these patients. In the following review, the authors discuss the salient features of the article, how the results of this trial are likely to change the management strategies in CS in the setting of AMI and the future directions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
